Skip to product information
1 of 1

rihanna oü

TauroLock U25.000

TauroLock U25.000

Regular price €156,00 EUR
Regular price Sale price €156,00 EUR
Sale Sold out
Tax included.


Our product range includes specialised catheter lock solutions for patients in different contexts. TauroLock™-U25.000 ensures a particularly strong prophylaxis against occlusion, thanks to the active ingredient urokinase.  

Indication and effect

TauroLock™-U25.000 has been approved for instillation in all central-venous access systems. This lock solution reliably prevents the formation of bacterial biofilms within catheters: Patients can avoid infections and maintain a high patency rate. 


TauroLock™-U25.000 is based on three active ingredients:

  • taurolidine
  • citrate (4 %)
  • urokinase (25,000 units per ml)

Taurolidine has a broad antimicrobial activity (incl. MRSA and VRE), while citrate works as an anticoagulant. Urokinase has a thrombolytic effect, breaking up blood clotting in its early stages. 


Before applying TauroLock™-U25.000, you need to dissolve the vial’s content (i.e. 25,000 IU urokinase) with 5 ml of TauroLock™. In-between treatment sessions, instil the clear, colourless solution into the vascular access system (VAD). Please note that medical staff should check the filling volume of each catheter or port system.

View full details